Early Phase Clinical Trials in Oncology and Hemato-Oncology: from Preclinical Research to Study Design and Management

The programme aims to train future professionals who will be able to work in a number of roles and settings. Within pharmaceutical companies, for example, they could take on the management and coordination of early phase clinical trials, or work as preclinical and clinical drug developers, bio-analytics and pharmacokinetics specialists, risk management and preclinical safety experts or pharmacovigilance and drug safety managers. Alternatively, they could be employed as Clinical Research Associates (CRA), also known as Clinical Monitors, or as project managers and study coordinators within phase I trials by Contract Research Organisations (CRO), or as clinical research laboratory managers by hospitals and medical centres. Within regulatory agencies, they could work as experts in the evaluation of clinical study protocols, ethics and compliance specialists, quality and regulatory managers, or clinical compliance consultants. Lastly, they could work for biomedical start-ups as innovation project leaders, preclinical drug developers and early phase specialists, fundraising managers and research project managers.